Abstract P2-09-22: Use of a Functional Signal Profiling Test with High Sensitivity and Specificity to Determine the Prevalence of Abnormal HER2-driven Signaling Activity in the HER2-negative Breast Cancer Patient Population: New Patient Group May Benefit from HER2 Therapy
Cancer Research（2018）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined